19:50:51 EDT Thu 25 Apr 2024
Enter Symbol
or Name
USA
CA



Shell Summary for May 13, 2015

2015-05-13 20:05 ET - Market Summary

This item is part of Stockwatch's value added news feed and is only available to Stockwatch subscribers.

Here is a sample of this item:

by Stockwatch Business Reporter

The TSX Venture Exchange added 1.29 points to 693.11 Wednesday. Michael Dalsin, Roger Greene and Robert Munro's Inspira Financial Inc. has closed yet another private placement as it prepares to go public through Marc Lavine and Mr. Munro's halted capital pool shell, Chrysalis Capital IX Corp. (NYN). Earlier this month it raised $15-million by selling 84,762,945 units at 15 cents and 2,228.75 debenture units at $1,000. Ten brokerage firms lined up 579 accredited purchasers to subscribe to this financing.

Among the hundreds of purchasers was David Dattels, who was able to secure a total of at least three million units for four funds that he manages through his Toronto hedge fund, NewGen Asset Management. Mr. Dattels, a former Canaccord Adams mining analyst, is the son of mining promoter Stephen Dattels, who has founded many mining companies and is a former director of Barrick Gold Corp. (ABX: $15.84). Other subscribers to Inspira's recent financing included Yoel Altman, a Toronto investor and chartered accountant, whose Grandhill Capital Inc. acquired one million units; Martin Bernholtz, an investor and businessman, 600,000 units; Nitin Kaushal, a director of Convalo Health International Corp. (CXV: $0.55), 500,000 units; Peter Kirby, a Canaccord broker, 250,000 units; and Brian Bayley, a part-time shell packager, 120,000 units and also 100 debenture units.

The remainder is available to Stockwatch subscribers.
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

© 2024 Canjex Publishing Ltd. All rights reserved.


Reader Comments - Comments are open to paying subscribers of Stockwatch and unmoderated, although libelous remarks, obscene language and impersonations may be deleted. Opinions expressed do not necessarily reflect the views of Stockwatch.
For information regarding Canadian libel law, please view the University of Ottawa's FAQ regarding Defamation and SLAPPs.


Comments for this item are closed